Projects funded by the NCN

Physicochemical characterization of cyclodextrins tailored for pH-dependent targeted therapy with anthracycline drugs

Call: OPUS 7 , Panel: ST5

Principal investigator: prof. Renata Bilewicz

Uniwersytet Warszawski, Wydział Chemii

Synthesis and application of multi-task, selective drug carriers to reduce the cardiotoxity and photosensitivity of anth...

Call: PRELUDIUM 1 , Panel: ST5

Principal investigator: Olga Święch

Uniwersytet Warszawski, Wydział Chemii

The effect of reductive activation of antitumour anthracycline antibiotics and their synthetic analogues on restoring cy...

Call: OPUS 3 , Panel: NZ3

Principal investigator: prof. Jolanta Tarasiuk

Uniwersytet Szczeciński, Wydział Biologii

Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

Call: PRELUDIUM 19 , Panel: NZ7

Principal investigator: Marek Jamrozik

Uniwersytet Jagielloński, Collegium Medicum

Factors influencing effective transport of anticancer drugs through cell membranes studied on the example of the interac...

Call: SONATA 12 , Panel: ST4

Principal investigator: dr Dorota Matyszewska

Uniwersytet Warszawski, Wydział Chemii

Inteligent oligosilsesquioxane nanoconjugates of anticancer drugs with targeting moieties.

Call: PRELUDIUM 11 , Panel: ST5

Principal investigator: Kinga Piórecka

Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk

Cardiovascular micro RNA fingerprint of anthracyclines - study in vitro and in vivo in long-term acute lymphoblastic leu...

Call: SONATA 9 , Panel: NZ7

Principal investigator: dr Justyna Totoń-Żurańska

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Lekarski